FDAClass IIJanuary 28, 2026

Icosapent Ethyl capsules recall: Subpotent

Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07

Why was Icosapent Ethyl capsules recalled?

Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules

What should I do if I have this product?

The recall is ongoing. Follow the firm and FDA instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot # S2520304, S2520333, Exp 2/28/2027; S2540186, Exp 4/30/2027

Product
Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-07
Recalling firm
Zydus Pharmaceuticals (USA) Inc
Quantity
22,896 bottles
Distribution
US Nationwide.
Recall date
January 28, 2026
Classification
Class II
Status
Ongoing
Agency
FDA (drug)
Open FDA enforcement record Latest recalls